Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study aims to uncover hidden heart risks in CKM syndrome

NCT ID NCT07697469

Not yet recruiting Knowledge-focused Sponsor: Grigore T. Popa University of Medicine and Pharmacy Source: ClinicalTrials.gov ↗

First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time

Summary

This study looks at how atrial cardiomyopathy—a condition where the heart's upper chambers are damaged—relates to cardiovascular-kidney-metabolic (CKM) syndrome, a cluster of heart, kidney, and metabolic problems. Researchers will use non-invasive tests like ECG, echocardiography, and blood markers to detect early signs of atrial damage in adults with CKM syndrome. The goal is to better understand the link between these conditions and improve prevention strategies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to better early detection and risk-stratification tools for atrial cardiomyopathy in people with CKM syndrome, potentially preventing complications like atrial fibrillation and stroke.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly test therapies. The findings may not apply to all populations or lead to immediate clinical changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL CARDIOMYOPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

abdominal obesity-metabolic syndrome atrial fibrillation Atrial Remodeling cardiovascular-kidney-metabolic syndrome chronic kidney disease chronic renal failure syndrome metabolic syndrome X

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATRIAL CARDIOMYOPATHY ATRIAL FIBRILLATION CARDIOVASCULAR KIDNEY METABOLIC SYNDROME CHRONIC KIDNEY DISEASE METABOLIC SYNDROME

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Internal Medicine Clinic I "Prof. Datcu" - Sf. Spiridon County Emergency Clinical Hospital

    Iași, Iaşi, 700111, Romania

More trials for these conditions

Other studies related to the condition(s) this trial covers.